nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—SLC22A11—Methotrexate—esophageal cancer	0.128	0.34	CbGbCtD
Minocycline—SLC22A7—Methotrexate—esophageal cancer	0.122	0.324	CbGbCtD
Minocycline—SLC22A8—Methotrexate—esophageal cancer	0.0742	0.198	CbGbCtD
Minocycline—SLC22A6—Methotrexate—esophageal cancer	0.0517	0.138	CbGbCtD
Minocycline—CYCS—exocrine gland—esophageal cancer	0.0139	0.0698	CbGeAlD
Minocycline—CASP3—exocrine gland—esophageal cancer	0.0119	0.0598	CbGeAlD
Minocycline—CYCS—neck—esophageal cancer	0.0089	0.0446	CbGeAlD
Minocycline—CASP3—neck—esophageal cancer	0.00763	0.0382	CbGeAlD
Minocycline—CASP1—epithelium—esophageal cancer	0.00629	0.0316	CbGeAlD
Minocycline—CASP1—bronchus—esophageal cancer	0.0062	0.0311	CbGeAlD
Minocycline—CYCS—epithelium—esophageal cancer	0.00606	0.0304	CbGeAlD
Minocycline—CYCS—bronchus—esophageal cancer	0.00597	0.0299	CbGeAlD
Minocycline—CYCS—smooth muscle tissue—esophageal cancer	0.00584	0.0293	CbGeAlD
Minocycline—CASP1—trachea—esophageal cancer	0.00557	0.0279	CbGeAlD
Minocycline—CASP3—epithelium—esophageal cancer	0.00519	0.026	CbGeAlD
Minocycline—CASP3—bronchus—esophageal cancer	0.00511	0.0256	CbGeAlD
Minocycline—MMP9—neck—esophageal cancer	0.00508	0.0255	CbGeAlD
Minocycline—CASP3—smooth muscle tissue—esophageal cancer	0.005	0.0251	CbGeAlD
Minocycline—CASP1—digestive system—esophageal cancer	0.00479	0.024	CbGeAlD
Minocycline—CYCS—digestive system—esophageal cancer	0.00461	0.0231	CbGeAlD
Minocycline—CASP3—trachea—esophageal cancer	0.00459	0.023	CbGeAlD
Minocycline—IL1B—epithelium—esophageal cancer	0.00415	0.0208	CbGeAlD
Minocycline—IL1B—bronchus—esophageal cancer	0.00408	0.0205	CbGeAlD
Minocycline—VEGFA—bronchus—esophageal cancer	0.00402	0.0201	CbGeAlD
Minocycline—CASP1—lung—esophageal cancer	0.004	0.02	CbGeAlD
Minocycline—IL1B—smooth muscle tissue—esophageal cancer	0.00399	0.02	CbGeAlD
Minocycline—CASP3—digestive system—esophageal cancer	0.00395	0.0198	CbGeAlD
Minocycline—VEGFA—smooth muscle tissue—esophageal cancer	0.00393	0.0197	CbGeAlD
Minocycline—CYCS—lung—esophageal cancer	0.00385	0.0193	CbGeAlD
Minocycline—VEGFA—trachea—esophageal cancer	0.00361	0.0181	CbGeAlD
Minocycline—MMP9—epithelium—esophageal cancer	0.00345	0.0173	CbGeAlD
Minocycline—MMP9—smooth muscle tissue—esophageal cancer	0.00333	0.0167	CbGeAlD
Minocycline—CASP3—lung—esophageal cancer	0.0033	0.0165	CbGeAlD
Minocycline—IL1B—digestive system—esophageal cancer	0.00315	0.0158	CbGeAlD
Minocycline—CASP1—lymph node—esophageal cancer	0.00274	0.0137	CbGeAlD
Minocycline—ALOX5—bronchus—esophageal cancer	0.00269	0.0135	CbGeAlD
Minocycline—IL1B—lung—esophageal cancer	0.00263	0.0132	CbGeAlD
Minocycline—CYCS—lymph node—esophageal cancer	0.00263	0.0132	CbGeAlD
Minocycline—ALOX5—smooth muscle tissue—esophageal cancer	0.00263	0.0132	CbGeAlD
Minocycline—MMP9—digestive system—esophageal cancer	0.00263	0.0132	CbGeAlD
Minocycline—VEGFA—lung—esophageal cancer	0.00259	0.013	CbGeAlD
Minocycline—SLC22A11—digestive system—esophageal cancer	0.00249	0.0125	CbGeAlD
Minocycline—SLC22A7—digestive system—esophageal cancer	0.00243	0.0122	CbGeAlD
Minocycline—CASP3—lymph node—esophageal cancer	0.00226	0.0113	CbGeAlD
Minocycline—MMP9—lung—esophageal cancer	0.0022	0.011	CbGeAlD
Minocycline—ALOX5—digestive system—esophageal cancer	0.00208	0.0104	CbGeAlD
Minocycline—IL1B—lymph node—esophageal cancer	0.0018	0.00903	CbGeAlD
Minocycline—VEGFA—lymph node—esophageal cancer	0.00177	0.00888	CbGeAlD
Minocycline—ALOX5—lung—esophageal cancer	0.00174	0.0087	CbGeAlD
Minocycline—MMP9—lymph node—esophageal cancer	0.0015	0.00753	CbGeAlD
Minocycline—ALOX5—lymph node—esophageal cancer	0.00119	0.00595	CbGeAlD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—esophageal cancer	7.27e-05	0.000171	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	7.25e-05	0.00017	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—SMAD4—esophageal cancer	7.22e-05	0.00017	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PSME2—esophageal cancer	7.22e-05	0.00017	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PSME1—esophageal cancer	7.22e-05	0.00017	CbGpPWpGaD
Minocycline—IL1B—Immune System—B2M—esophageal cancer	7.22e-05	0.00017	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ADH1B—esophageal cancer	7.19e-05	0.000169	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—PIK3CA—esophageal cancer	7.18e-05	0.000169	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—EP300—esophageal cancer	7.18e-05	0.000169	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KMT2D—esophageal cancer	7.14e-05	0.000168	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ELMO1—esophageal cancer	6.96e-05	0.000164	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—esophageal cancer	6.93e-05	0.000163	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CREBBP—esophageal cancer	6.92e-05	0.000163	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—RB1—esophageal cancer	6.89e-05	0.000162	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—KDR—esophageal cancer	6.87e-05	0.000162	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TYMP—esophageal cancer	6.87e-05	0.000161	CbGpPWpGaD
Minocycline—IL1B—Immune System—PSME1—esophageal cancer	6.82e-05	0.00016	CbGpPWpGaD
Minocycline—IL1B—Immune System—PSME2—esophageal cancer	6.82e-05	0.00016	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.81e-05	0.00016	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKAP13—esophageal cancer	6.8e-05	0.00016	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—PIK3CA—esophageal cancer	6.78e-05	0.000159	CbGpPWpGaD
Minocycline—IL1B—Immune System—HSPA5—esophageal cancer	6.75e-05	0.000159	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MET—esophageal cancer	6.73e-05	0.000158	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—WWOX—esophageal cancer	6.7e-05	0.000157	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP26A1—esophageal cancer	6.68e-05	0.000157	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—CCND1—esophageal cancer	6.66e-05	0.000156	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	6.63e-05	0.000156	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—PIK3CA—esophageal cancer	6.63e-05	0.000156	CbGpPWpGaD
Minocycline—IL1B—Immune System—CALR—esophageal cancer	6.54e-05	0.000154	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ALOX15—esophageal cancer	6.51e-05	0.000153	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—ABL1—esophageal cancer	6.47e-05	0.000152	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—MYC—esophageal cancer	6.42e-05	0.000151	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	6.41e-05	0.000151	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FKBP1A—esophageal cancer	6.37e-05	0.00015	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CDKN1A—esophageal cancer	6.37e-05	0.00015	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADCYAP1—esophageal cancer	6.36e-05	0.000149	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—ABL1—esophageal cancer	6.35e-05	0.000149	CbGpPWpGaD
Minocycline—IL1B—Immune System—FBXW7—esophageal cancer	6.33e-05	0.000149	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	6.28e-05	0.000148	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HIST1H2BM—esophageal cancer	6.28e-05	0.000148	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—SMAD4—esophageal cancer	6.27e-05	0.000147	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—EGFR—esophageal cancer	6.25e-05	0.000147	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—WIF1—esophageal cancer	6.23e-05	0.000146	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP1B1—esophageal cancer	6.23e-05	0.000146	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PDE4D—esophageal cancer	6.22e-05	0.000146	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTO1—esophageal cancer	6.21e-05	0.000146	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TPI1—esophageal cancer	6.21e-05	0.000146	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	6.18e-05	0.000145	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	6.1e-05	0.000143	CbGpPWpGaD
Minocycline—CASP1—Immune System—TLR4—esophageal cancer	6.06e-05	0.000143	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDKN2A—esophageal cancer	6.06e-05	0.000142	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—EP300—esophageal cancer	6.06e-05	0.000142	CbGpPWpGaD
Minocycline—IL1B—Immune System—HMGB1—esophageal cancer	6.05e-05	0.000142	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ALDOB—esophageal cancer	5.95e-05	0.00014	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.92e-05	0.000139	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GNG7—esophageal cancer	5.92e-05	0.000139	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP19A1—esophageal cancer	5.85e-05	0.000138	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—WWOX—esophageal cancer	5.82e-05	0.000137	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CSNK1A1—esophageal cancer	5.75e-05	0.000135	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GAPDH—esophageal cancer	5.73e-05	0.000135	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CRABP1—esophageal cancer	5.68e-05	0.000134	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.68e-05	0.000133	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—ERBB2—esophageal cancer	5.66e-05	0.000133	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—KDR—esophageal cancer	5.65e-05	0.000133	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—XIAP—esophageal cancer	5.54e-05	0.00013	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FKBP1A—esophageal cancer	5.53e-05	0.00013	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MET—esophageal cancer	5.53e-05	0.00013	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—PIK3CA—esophageal cancer	5.42e-05	0.000127	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—WIF1—esophageal cancer	5.41e-05	0.000127	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GNG7—esophageal cancer	5.4e-05	0.000127	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PFN1—esophageal cancer	5.38e-05	0.000126	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.37e-05	0.000126	CbGpPWpGaD
Minocycline—CYCS—Metabolism—HMOX1—esophageal cancer	5.34e-05	0.000126	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NOTCH1—esophageal cancer	5.32e-05	0.000125	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	5.32e-05	0.000125	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—esophageal cancer	5.27e-05	0.000124	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CTNNA1—esophageal cancer	5.24e-05	0.000123	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—EGFR—esophageal cancer	5.22e-05	0.000123	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL2—esophageal cancer	5.21e-05	0.000123	CbGpPWpGaD
Minocycline—CASP1—Immune System—CASP8—esophageal cancer	5.2e-05	0.000122	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	5.2e-05	0.000122	CbGpPWpGaD
Minocycline—CASP1—Immune System—CREBBP—esophageal cancer	5.18e-05	0.000122	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—EGFR—esophageal cancer	5.16e-05	0.000121	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.15e-05	0.000121	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ABCB1—esophageal cancer	5.13e-05	0.000121	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ALDH2—esophageal cancer	5.06e-05	0.000119	CbGpPWpGaD
Minocycline—IL1B—Immune System—ABL1—esophageal cancer	5e-05	0.000118	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—PIK3CA—esophageal cancer	4.99e-05	0.000117	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CSNK1A1—esophageal cancer	4.99e-05	0.000117	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDKN1A—esophageal cancer	4.95e-05	0.000116	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—ERBB2—esophageal cancer	4.92e-05	0.000116	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—KDR—esophageal cancer	4.91e-05	0.000115	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PSME1—esophageal cancer	4.87e-05	0.000114	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PSME2—esophageal cancer	4.87e-05	0.000114	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ANXA1—esophageal cancer	4.85e-05	0.000114	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ELMO1—esophageal cancer	4.83e-05	0.000114	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CREBBP—esophageal cancer	4.83e-05	0.000113	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTT1—esophageal cancer	4.82e-05	0.000113	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MET—esophageal cancer	4.8e-05	0.000113	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP2A6—esophageal cancer	4.76e-05	0.000112	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.74e-05	0.000111	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKAP13—esophageal cancer	4.72e-05	0.000111	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SST—esophageal cancer	4.71e-05	0.000111	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—EP300—esophageal cancer	4.71e-05	0.000111	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PFN1—esophageal cancer	4.67e-05	0.00011	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NOTCH1—esophageal cancer	4.62e-05	0.000109	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GHRL—esophageal cancer	4.59e-05	0.000108	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOTCH3—esophageal cancer	4.59e-05	0.000108	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NOS2—esophageal cancer	4.58e-05	0.000108	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—PIK3CA—esophageal cancer	4.53e-05	0.000107	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FBXW7—esophageal cancer	4.52e-05	0.000106	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	4.51e-05	0.000106	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ENO1—esophageal cancer	4.51e-05	0.000106	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS1—esophageal cancer	4.51e-05	0.000106	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.51e-05	0.000106	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—PIK3CA—esophageal cancer	4.48e-05	0.000105	CbGpPWpGaD
Minocycline—CASP1—Immune System—BCL2—esophageal cancer	4.46e-05	0.000105	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PSME1—esophageal cancer	4.45e-05	0.000105	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PSME2—esophageal cancer	4.45e-05	0.000105	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	4.37e-05	0.000103	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HIST1H2BM—esophageal cancer	4.36e-05	0.000102	CbGpPWpGaD
Minocycline—CASP1—Immune System—ERBB2—esophageal cancer	4.34e-05	0.000102	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.33e-05	0.000102	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PDE4D—esophageal cancer	4.32e-05	0.000101	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ELMO1—esophageal cancer	4.19e-05	9.85e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CREBBP—esophageal cancer	4.19e-05	9.85e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOTCH2—esophageal cancer	4.12e-05	9.68e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—CREBBP—esophageal cancer	4.11e-05	9.66e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GNG7—esophageal cancer	4.11e-05	9.65e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKAP13—esophageal cancer	4.1e-05	9.63e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—ERBB2—esophageal cancer	4.04e-05	9.5e-05	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	4.02e-05	9.44e-05	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—EGFR—esophageal cancer	3.93e-05	9.23e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.88e-05	9.13e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—XIAP—esophageal cancer	3.85e-05	9.05e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP1B1—esophageal cancer	3.84e-05	9.02e-05	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.8e-05	8.92e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—TLR4—esophageal cancer	3.79e-05	8.91e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HIST1H2BM—esophageal cancer	3.78e-05	8.89e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.77e-05	8.85e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PDE4D—esophageal cancer	3.75e-05	8.81e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—CDKN1A—esophageal cancer	3.71e-05	8.71e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NOS3—esophageal cancer	3.68e-05	8.65e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFBR2—esophageal cancer	3.66e-05	8.59e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CTNNA1—esophageal cancer	3.64e-05	8.55e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL2—esophageal cancer	3.62e-05	8.5e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.61e-05	8.5e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP19A1—esophageal cancer	3.61e-05	8.48e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GNG7—esophageal cancer	3.57e-05	8.38e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—EP300—esophageal cancer	3.53e-05	8.29e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—ERBB2—esophageal cancer	3.51e-05	8.25e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SMAD4—esophageal cancer	3.46e-05	8.13e-05	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.44e-05	8.09e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CREBBP—esophageal cancer	3.43e-05	8.05e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—EGFR—esophageal cancer	3.41e-05	8.01e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PSME2—esophageal cancer	3.38e-05	7.94e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PSME1—esophageal cancer	3.38e-05	7.94e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—esophageal cancer	3.37e-05	7.92e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ANXA1—esophageal cancer	3.36e-05	7.91e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—XIAP—esophageal cancer	3.34e-05	7.85e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—HMOX1—esophageal cancer	3.29e-05	7.74e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EP300—esophageal cancer	3.29e-05	7.73e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SST—esophageal cancer	3.27e-05	7.69e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CASP8—esophageal cancer	3.25e-05	7.64e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CREBBP—esophageal cancer	3.24e-05	7.61e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.23e-05	7.59e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOTCH3—esophageal cancer	3.19e-05	7.49e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GHRL—esophageal cancer	3.19e-05	7.49e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ABCB1—esophageal cancer	3.16e-05	7.43e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CTNNA1—esophageal cancer	3.16e-05	7.43e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL2—esophageal cancer	3.14e-05	7.38e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FBXW7—esophageal cancer	3.14e-05	7.37e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NOS3—esophageal cancer	3.07e-05	7.21e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—EGFR—esophageal cancer	3.01e-05	7.07e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PSME2—esophageal cancer	2.93e-05	6.9e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PSME1—esophageal cancer	2.93e-05	6.9e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ANXA1—esophageal cancer	2.92e-05	6.86e-05	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.89e-05	6.8e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOTCH2—esophageal cancer	2.86e-05	6.72e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EP300—esophageal cancer	2.85e-05	6.71e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SST—esophageal cancer	2.84e-05	6.68e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HIF1A—esophageal cancer	2.83e-05	6.65e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—esophageal cancer	2.81e-05	6.6e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EGFR—esophageal cancer	2.8e-05	6.59e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—EP300—esophageal cancer	2.8e-05	6.58e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—BCL2—esophageal cancer	2.79e-05	6.56e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOTCH3—esophageal cancer	2.77e-05	6.51e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GHRL—esophageal cancer	2.77e-05	6.51e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FBXW7—esophageal cancer	2.72e-05	6.4e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—ERBB2—esophageal cancer	2.71e-05	6.37e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—KDR—esophageal cancer	2.71e-05	6.36e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—PIK3CA—esophageal cancer	2.61e-05	6.13e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOTCH1—esophageal cancer	2.55e-05	5.99e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFBR2—esophageal cancer	2.54e-05	5.96e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOTCH2—esophageal cancer	2.48e-05	5.84e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EGFR—esophageal cancer	2.43e-05	5.72e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.42e-05	5.68e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SMAD4—esophageal cancer	2.4e-05	5.65e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.39e-05	5.61e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—EP300—esophageal cancer	2.33e-05	5.49e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CDKN1A—esophageal cancer	2.32e-05	5.45e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CREBBP—esophageal cancer	2.31e-05	5.43e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—EP300—esophageal cancer	2.2e-05	5.18e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFBR2—esophageal cancer	2.2e-05	5.18e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CREBBP—esophageal cancer	2.11e-05	4.96e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SMAD4—esophageal cancer	2.09e-05	4.9e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PIK3CA—esophageal cancer	2.07e-05	4.87e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOS3—esophageal cancer	2.07e-05	4.87e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—esophageal cancer	2e-05	4.71e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HIF1A—esophageal cancer	1.97e-05	4.62e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ERBB2—esophageal cancer	1.94e-05	4.55e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NOS3—esophageal cancer	1.89e-05	4.44e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KDR—esophageal cancer	1.88e-05	4.42e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—EGFR—esophageal cancer	1.88e-05	4.42e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOTCH1—esophageal cancer	1.77e-05	4.16e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—esophageal cancer	1.73e-05	4.06e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PIK3CA—esophageal cancer	1.73e-05	4.06e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCND1—esophageal cancer	1.71e-05	4.02e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HIF1A—esophageal cancer	1.71e-05	4.01e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CDKN1A—esophageal cancer	1.66e-05	3.89e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KDR—esophageal cancer	1.63e-05	3.83e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—PIK3CA—esophageal cancer	1.63e-05	3.83e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CREBBP—esophageal cancer	1.61e-05	3.77e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EP300—esophageal cancer	1.57e-05	3.7e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOTCH1—esophageal cancer	1.54e-05	3.61e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—EP300—esophageal cancer	1.44e-05	3.38e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOS3—esophageal cancer	1.44e-05	3.38e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CREBBP—esophageal cancer	1.39e-05	3.28e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MYC—esophageal cancer	1.37e-05	3.23e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ERBB2—esophageal cancer	1.34e-05	3.16e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EGFR—esophageal cancer	1.34e-05	3.15e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOS3—esophageal cancer	1.25e-05	2.93e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCND1—esophageal cancer	1.19e-05	2.79e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ERBB2—esophageal cancer	1.17e-05	2.74e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PIK3CA—esophageal cancer	1.17e-05	2.74e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CDKN1A—esophageal cancer	1.15e-05	2.7e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—esophageal cancer	1.13e-05	2.65e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EP300—esophageal cancer	1.09e-05	2.57e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3CA—esophageal cancer	1.06e-05	2.5e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCND1—esophageal cancer	1.03e-05	2.42e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CDKN1A—esophageal cancer	9.97e-06	2.34e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MYC—esophageal cancer	9.53e-06	2.24e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EP300—esophageal cancer	9.49e-06	2.23e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EGFR—esophageal cancer	9.32e-06	2.19e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MYC—esophageal cancer	8.27e-06	1.94e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EGFR—esophageal cancer	8.09e-06	1.9e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PIK3CA—esophageal cancer	8.09e-06	1.9e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—esophageal cancer	7.82e-06	1.84e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PIK3CA—esophageal cancer	7.02e-06	1.65e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—esophageal cancer	6.79e-06	1.6e-05	CbGpPWpGaD
